Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
6.19
-0.04 (-0.64%)
At close: Mar 9, 2026, 4:00 PM EDT
6.07
-0.12 (-1.94%)
After-hours: Mar 9, 2026, 6:33 PM EDT

Silence Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-88.61-45.31-54.23-50.33-53.36
Upgrade
Depreciation & Amortization
0.560.590.620.60.58
Upgrade
Stock-Based Compensation
8.0716.3116.2712.6911.69
Upgrade
Other Operating Activities
7.55-6.213.12-0.6-2.29
Upgrade
Change in Accounts Receivable
1.02-0.90.39-0.7237.21
Upgrade
Change in Accounts Payable
-4.080.5-0.472.023.26
Upgrade
Change in Unearned Revenue
-0.33-28.79-10.32-5.4411.33
Upgrade
Change in Other Net Operating Assets
13.55-3.83-4.84-15.260.8
Upgrade
Operating Cash Flow
-62.27-67.64-49.46-57.049.22
Upgrade
Capital Expenditures
-0.06-0.21-0.06-0.17-1.78
Upgrade
Sale (Purchase) of Intangibles
----0.37-0.03
Upgrade
Investment in Securities
-47.94-21.7619.35-19.9513.54
Upgrade
Other Investing Activities
----0.01
Upgrade
Investing Cash Flow
-47.99-21.9719.29-20.511.75
Upgrade
Long-Term Debt Repaid
-----0.29
Upgrade
Net Debt Issued (Repaid)
-----0.29
Upgrade
Issuance of Common Stock
0.02142.0931.9452.5841.87
Upgrade
Financing Cash Flow
0.02142.0931.9452.5841.58
Upgrade
Foreign Exchange Rate Adjustments
0.20.060.75-8.12-0.14
Upgrade
Net Cash Flow
-110.0552.542.52-33.0862.41
Upgrade
Free Cash Flow
-62.33-67.85-49.52-57.227.44
Upgrade
Free Cash Flow Margin
-11149.55%-156.85%-156.49%-264.22%44.26%
Upgrade
Free Cash Flow Per Share
-1.32-1.47-1.33-1.780.25
Upgrade
Cash Income Tax Paid
0.640.430.8--
Upgrade
Levered Free Cash Flow
-39.55-25.37-23.31-26.84-6.72
Upgrade
Unlevered Free Cash Flow
-39.55-25.37-23.31-26.84-6.71
Upgrade
Change in Working Capital
10.16-33.02-15.24-19.452.6
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.